NCT03438058View on ClinicalTrials.gov

Complement-activating Anti-human Leucocyte Antigen Donor Specific Antibodies in Solid Organ Transplantation

CompletedOBSERVATIONAL
Enrollment

7,547

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

January 31, 2018

Study Completion Date

February 28, 2018

Conditions
Organ Transplant Recipients
Interventions
OTHER

Graft survival and/or Rejection appearance

All Listed Sponsors
lead

Paris Translational Research Center for Organ Transplantation

OTHER

NCT03438058 - Complement-activating Anti-human Leucocyte Antigen Donor Specific Antibodies in Solid Organ Transplantation | Biotech Hunter | Biotech Hunter